UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000028954
Receipt No. R000033132
Scientific Title Investigation of risk factors for malignant tumor, cardiovascular diseases, and lifestyle related diseases in the health check-up population in Japan.
Date of disclosure of the study information 2017/09/15
Last modified on 2019/09/03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Investigation of risk factors for malignant tumor, cardiovascular diseases, and lifestyle related diseases in the health check-up population in Japan.
Acronym NAGOYA Health Check Study (NHC study)
Scientific Title Investigation of risk factors for malignant tumor, cardiovascular diseases, and lifestyle related diseases in the health check-up population in Japan.
Scientific Title:Acronym NAGOYA Health Check Study (NHC study)
Region
Japan

Condition
Condition Cardiovascular diseases, lifestyle related diseases, malignant tumor, arteriosclerosis, etc
Classification by specialty
Not applicable Adult
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To investigate the risk factors of malignant tumor, cardiovascular diseases, lifestyle related diseases, and arteriosclerosis using the health check-up data.
Basic objectives2 Others
Basic objectives -Others To elucidate the high risk population for above mentined diseases based on the prospective or retrospective cohort studies using health check-up data.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The incidence of lifestyle related diseases; hypertension, dyslipidemia, metabolic syndrome, CKD.
The incidence of cardiovascular diseases.
The incidence of malignant tumor.
Key secondary outcomes The signs of arteriosclerosis.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria Those who underwent health check-up at Kokusai Central Clinic, or Dai-Nagoya-Building Central Clinic after 2010.
Key exclusion criteria Those who were under 20 year-old at visiting our clinics.
Those who did not agree with this study.
Target sample size 70000

Research contact person
Name of lead principal investigator
1st name Kengo
Middle name
Last name Maeda
Organization Kokusai Central Clinic
Dai-Nagoya-Building Central Clinic
Division name Internal Medicine
Zip code 450-0001
Address 1-47-1 Nagono Nakamura-ku Nagoya Aichi
TEL 052-521-0633
Email maedaken@central-cl.or.jp

Public contact
Name of contact person
1st name Kengo
Middle name
Last name Maeda
Organization Kokusai Central Clinic
Division name Internal Medicine
Zip code 450-0001
Address 1-47-1 Nagono Nakamura-ku Nagoya Aichi
TEL 052-521-0633
Homepage URL
Email maedaken@central-cl.or.jp

Sponsor
Institute Kokusai Central Clinic
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethics Comittee of Japan Medical Association
Address 2-28-8 Motokomagome Bunkyo-ku Tokyo
Tel 03-5319-3781
Email rinri@jmacct.med.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 09 Month 15 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
We perfomed a retrpspective cohort study using data from 2010 to 2017. We reported that, in Japanese male health checkup examinees, hyperuricemia augmented incident hypertension independently of renal injury. 
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2017 Year 07 Month 18 Day
Date of IRB
2017 Year 08 Month 29 Day
Anticipated trial start date
2017 Year 09 Month 01 Day
Last follow-up date
2027 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information We will conduct the prospective or retrospective observational cohort study using the data of participants who visit our clinics after 2010.
We will analyze the accumulating data yearly, and publish the findings.
We will follow up the participants until Mar 31, 2027.

Management information
Registered date
2017 Year 09 Month 01 Day
Last modified on
2019 Year 09 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033132

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.